# Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV

> **NCT05005156** · PHASE2 · COMPLETED · sponsor: **Fundación Huésped** · enrollment: 155 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV)

## Key facts

- **NCT ID:** NCT05005156
- **Lead sponsor:** Fundación Huésped
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-24
- **Primary completion:** 2023-01-13
- **Final completion:** 2023-01-13
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2025-06-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05005156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05005156, "Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05005156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*